Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

BACKGROUND: Evidence of adverse clinical outcomes for non-vitamin K antagonist oral anticoagulant (NOACs) and warfarin in patients with atrial fibrillation (AF) and diabetes mellitus are limited. We investigated the effectiveness, safety, and major adverse limb events for NOACs versus warfarin among...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Yi-Hsin, Lee, Hsin-Fu, Li, Pei-Ru, Liu, Jia-Rou, Chao, Tze-Fan, Wu, Lung-Sheng, Chang, Shang-Hung, Yeh, Yung-Hsin, Kuo, Chi-Tai, See, Lai-Chu, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222472/
https://www.ncbi.nlm.nih.gov/pubmed/32404168
http://dx.doi.org/10.1186/s12933-020-01043-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222472/
https://www.ncbi.nlm.nih.gov/pubmed/32404168
http://dx.doi.org/10.1186/s12933-020-01043-2

Ejemplares similares